EXCEPTIONALLY LOW LIKELIHOOD OF ALZHEIMER'S DEMENTIA IN APOE2 HOMOZYGOTES
By
Eric M. Reiman,
Joseph F. Arboleda-Velasquez,
Yakeel T. Quiroz,
Matthew Huentelman,
Thomas G Beach,
Richard J Caselli,
Yinghua Chen,
Yi Su,
Amanda J. Myers,
John Hardy,
Jean Paul Vonsattel,
Steven G. Younkin,
David A. Bennett,
Phillip De Jager,
Eric B Larson,
Paul K. Crane,
C. Dirk Keene,
M. Ilyas Kamboh,
Julia K. Kofler,
Linda Duque,
John R. Gilbert,
Harry E. Gwirtsman,
Joseph Buxbaum,
Dennis W. Dickson,
Matthew P Frosch,
Bernardino Ghetti,
Kathryn L. Lunetta,
Li-San Wang,
Bradley T Hyman,
Walter A. Kukull,
Tatiana Foroud,
Jonathan L. Haines,
Richard P. Mayeux,
Margaret A. Pericak-Vance,
Julie A Schneider,
John Q Trojanowski,
Lindsay A. Farrer,
Gerard D. Schellenberg,
Gary W Beecham,
Thomas J. Montine,
Gyungah R. Jun,
for the Alzheimer’s Disease Genetics Consortium
Posted 02 Nov 2019
medRxiv DOI: 10.1101/19011015
Each additional copy of the apolipoprotein E4 (APOE4) allele is associated with a higher risk of Alzheimers dementia, such that APOE4 homozygotes have a particularly high risk. While the APOE2 allele is associated with a lower risk of Alzheimers dementia, it is not yet known whether APOE2 homozygotes have a particularly low risk. We generated Alzheimers dementia odds ratios and other findings in more than 5,000 clinically characterized and neuropathologically characterized Alzheimers dementia cases and controls. APOE2/2 was associated with exceptionally low Alzheimers dementia odds ratios compared to APOE2/3, 3/3 and 4/4, and the impact of APOE2 and APOE4 gene dose was significantly greater in the neuropathologically confirmed group than in more than 24,000 neuropathologically unconfirmed cases and controls. Finding and targeting the factors by which APOE and its variants influence Alzheimers disease could have a major impact on the understanding, treatment and prevention of this terrible disease.
Download data
- Downloaded 4,028 times
- Download rankings, all-time:
- Site-wide: 2,352
- In pathology: 18
- Year to date:
- Site-wide: 31,949
- Since beginning of last month:
- Site-wide: 6,918
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!